Journals / Southern Clinics of Istanbul Eurasia / 2021 / Cilt: 32 - Sayı: 1

Postmastectomy Pain Syndrome: A Retrospective Cohort Study About the Relationship of Histopathological Type and Comorbidities

Pages
64–68
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, we think that this relationship can be revealed more clearly with prospective studies in which every pathological diagnosis is grouped equally.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Although many risk factors that cause postmastectomy pain syndrome (PMPS) have been searched, in literature, no study was found on the pathological type and the presence of additional diseases.
📊
Key Findings & Data:Methods: The data of 392 patients who underwent mastectomy for breast cancer between the years 2008 and 2016 were analyzed retrospectively.
💡
Conclusion & Impact:Therefore, we think that this relationship can be revealed more clearly with prospective studies in which every pathological diagnosis is grouped equally.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Although many risk factors that cause postmastectomy pain syndrome (PMPS) have been searched, in literature, no study was found on the pathological type and the presence of additional diseases. Its aimed to evaluate the frequency of PMPS and probability of being a risk factor of pathological type and the presence of additional diseases in whom underwent mastectomy for breast cancer. Methods: The data of 392 patients who underwent mastectomy for breast cancer between the years 2008 and 2016 were analyzed retrospectively. Demographic data, surgery type, radiotherapy, chemotherapy, presence of additional diseases, the pathologic diagnosis of the tumor, axillary dissection, number of total and metastatic lymph nodes, application status of the patients to Algology Clinic, VAS, Gabapentin, and/or Pregabalin usage were investigated. Gabapentin and/or Pregabalin usage was accepted as the presence of PMPS. Results: In our study, PMPS incidence was 24.4%. Statistically significant difference was detected between older age (>50; 72.6%) and hypertension (33.3%) with PMPS. The type of surgery, axillary dissection, number of total and metastatic lymph nodes, radiotherapy, chemotherapy, and the pathological diagnosis of tumor were not determined as risk factors. Conclusion: Our determination of hypertension as a risk factor for PMPS with advanced age suggests that there is a need for prospective studies that address advanced age and hypertension. In addition, due to the retrospective study feature, an equal number of subgroups could not be made for all pathological types. Therefore, we think that this relationship can be revealed more clearly with prospective studies in which every pathological diagnosis is grouped equally.

🔖

Cite This Article

SAGÜN, A., ATICI, Ş. R., KARABAKAN, G., DAĞ, A., AZİZOĞLU, M. (2021). Postmastectomy Pain Syndrome: A Retrospective Cohort Study About the Relationship of Histopathological Type and Comorbidities. Southern Clinics of Istanbul Eurasia, Cilt: 32 - Sayı: 1, 64–68. https://ajindex.com/articles/314002

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90
  2. Ministry of Health Health Statistics Annual 2010:27−8. Available at: http://sbu.saglik.gov.tr/Ekutuphane/kitaplar/saglikistatistikleriyilligi2010. pdf. Accessed Feb 16, 2021
  3. Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003;89:648‑52
  4. Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S. Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study. Reg Anesth Pain Med 2019;44:192–9
  5. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: A critical review of risk factors and strategies for prevention. J Pain 2011;12:725‑46
  6. Couceiro TC, Valença MM, Raposo M, Orange FA, Amorim MM. Prevalence of post-mastectomy pain syndrome and associated risk factors: a cross-sectional cohort study. Pain Manag Nurs 2014;15:731–7
  7. Alves NFE, Bergmann A, do Amaral ESB, Padula RAC, de Souza AK, da Costa LFMG, et al. Post-mastectomy pain syndrome: incidence and risks. Breast 2021;21:321–5
  8. Meijuan Y, Zhiyou P, Yuwen T, Yin F, Xinzhong C. A retrospective study of postmastectomy pain syndrome: incidence, characteristics, risk factors, and influence on quality of life. Scientific World Journal 2013;2013:159732
  9. Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009;302:1985–92
  10. Chiang DLC, Rice DA, Helsby NA, Somogyi AA, Kluger MT. The Prevalence, Impact, and Risk Factors for Persistent Pain After Breast Cancer Surgery in a New Zealand Population. Pain Med 2019;20:1803–14
  11. Wang L, Guyatt GH, Kennedy SA, Romerosa B, Kwon HY, Kaushal A et al. Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ 2016;188:E352–E61
  12. Waltho D, Rockwell G. Post-breast surgery pain syndrome: establishing a consensus for the definition of postmastectomy pain syndrome to provide a standardized clinical and research approach—a review of the literature and discussion. Can J Surg 2016;59:342–50
  13. Feeney LR, Tormey SM, Harmon DC. Breast cancer and chronic pain: a mixed methods review. Ir J Med Sci 2018;187:877–85
  14. Kim HJ, Kim SY, Huh S. Multimoda